CN106214880A - A kind of wasp wine treating gout - Google Patents
A kind of wasp wine treating gout Download PDFInfo
- Publication number
- CN106214880A CN106214880A CN201610914510.9A CN201610914510A CN106214880A CN 106214880 A CN106214880 A CN 106214880A CN 201610914510 A CN201610914510 A CN 201610914510A CN 106214880 A CN106214880 A CN 106214880A
- Authority
- CN
- China
- Prior art keywords
- parts
- wasp
- wine
- fresh
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000014101 wine Nutrition 0.000 title claims abstract description 30
- 201000005569 Gout Diseases 0.000 title claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 25
- 235000019991 rice wine Nutrition 0.000 claims abstract description 20
- 241000628997 Flos Species 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims description 5
- 238000007654 immersion Methods 0.000 claims description 4
- 238000004137 mechanical activation Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 18
- 239000008280 blood Substances 0.000 abstract description 17
- 210000004369 blood Anatomy 0.000 abstract description 17
- 239000003814 drug Substances 0.000 abstract description 11
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 210000000952 spleen Anatomy 0.000 abstract description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 208000026435 phlegm Diseases 0.000 abstract description 5
- 230000003213 activating effect Effects 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 238000009472 formulation Methods 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- 230000008506 pathogenesis Effects 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 231100000614 poison Toxicity 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 6
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 6
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 229940116269 uric acid Drugs 0.000 description 6
- 206010003246 arthritis Diseases 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 244000061474 Bombax ceiba Species 0.000 description 1
- 206010065553 Bone marrow failure Diseases 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 241000220284 Crassulaceae Species 0.000 description 1
- 241000514824 Cyathula officinalis Species 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 206010070968 Disorders of purine metabolism Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010019837 Hepatocellular injury Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 241000146029 Lindera aggregata Species 0.000 description 1
- 241000304368 Orostachys fimbriata Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 241000222355 Trametes versicolor Species 0.000 description 1
- 206010048302 Tubulointerstitial nephritis Diseases 0.000 description 1
- 241000256856 Vespidae Species 0.000 description 1
- 208000026816 acute arthritis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000002961 anti-hyperuricemic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 231100000850 chronic interstitial nephritis Toxicity 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 208000035474 group of disease Diseases 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 description 1
- 229960003081 probenecid Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of wasp wine treating gout, belong to health promoting wine technical field.Described wasp wine, is prepared by the raw materials in: the rice wine 500 of 50~60 °~1500 parts, fresh and alive wasp 100~200 parts, Coriolous Dersicolor (Fr.) Quel 15~25 parts, the Radix Linderae 15~25 parts, Flos Bombacis Malabarici 10~20 parts, Rhizoma Alismatis 10~20 parts, Herba Orostachyos 5~15 parts, Radix Cyathulae 10~20 parts.Inventive formulation is scientific and reasonable, and all medicines coordinate, and plays invigorating spleen and kidney altogether, reduces phlegm that it is turbid to let out, and the turbid descending detoxifies, the merit of activating blood circulation to dissipate blood stasis;Full side's treating both the principal and the secondary aspects of a disease at the same time, appropriate pathogenesis.Through clinic trial, treatment gout effect is notable.
Description
[technical field]
The present invention relates to field of health care wine, be specifically related to a kind of wasp wine treating gout.
[background technology]
Gout is a kind of to cause one group of disease of tissue injury, also known as " high because long-term disorders of purine metabolism, blood uric acid increase
Hyperuricemia ", belong to arthritic one, also known as metabolic arthritis.Gout morbidity has obvious heterogeneity, except antihyperuricemic
Acute arthritis, tophus, chronic arthritis, joint deformity, chronic interstitial nephritis and uric acid urinary tract is can behave as outside disease
Calculus.The clinical manifestation of patient with gout is affected joints significantly redness, burning pain, often in night-time attack, wakes up because of joint severe pain,
Local joint can not touch because of pain, even can not lid sheet, limitation of activity, patient's distress level is bigger.
Being at present main for using Western medicine the treatment of gout, conventional have a colchicine, nonsteroidal anti-inflammatory analgetic more,
Adrenal Glucocorticoid and probenecid etc., although this type of Western medicine instant effect, but the most simply play and alleviate ailing purpose, difficult
To reach the purpose of radical cure, after drug withdrawal, slight illness is easy to and recurs, and this type of medicine often toxic and side effects is bigger, except drawing
Rising outside gastrointestinal reaction, long-term taking also can result in bone marrow depression, hepatocellular damage, spirit depressing, ascending paralysis, breathing
Suppression etc..And the Chinese medicine for gout is treated, there is SIMIAOYONGAN TANG, JUANBI TANG, Traditional Chinese medicine decoction for treating-ache and expelling atagnate, clearing away heat-damp and promoting diuresis eliminating impediment side
Deng, belong to Chinese medicine ancient prescription more, though there being certain curative effect, but Chinese medicines soup decoction process is complicated, and onset is slow, and the course for the treatment of is long, and to portion
Divide patient's curative effect inconspicuous.
[summary of the invention]
The goal of the invention of the present invention is: for the problem of above-mentioned existence, it is provided that a kind of wasp wine treating gout, described
Wasp wine scientific formulation is reasonable, and through clinic trial, treatment gout is evident in efficacy.
To achieve these goals, the technical solution used in the present invention is as follows:
A kind of wasp wine treating gout, is prepared by the raw materials in: the rice wine 500 of 50~60 °~1500 parts,
Fresh and alive wasp 100~200 parts, Coriolous Dersicolor (Fr.) Quel 15~25 parts, the Radix Linderae 15~25 parts, Flos Bombacis Malabarici 10~20 parts, Rhizoma Alismatis 10~20 parts, Herba Orostachyos
5~15 parts, Radix Cyathulae 10~20 parts.
Preferably, described wasp wine, it is prepared by the raw materials in: 500 parts of the rice wine of 50 °, fresh and alive wasp 100
Part, Coriolous Dersicolor (Fr.) Quel 15 parts, the Radix Linderae 15 parts, Flos Bombacis Malabarici 10 parts, Rhizoma Alismatis 10 parts, Herba Orostachyos 5 parts, Radix Cyathulae 10 parts.
Preferably, described wasp wine, it is prepared by the raw materials in: 1500 parts of the rice wine of 60 °, fresh and alive wasp
200 parts, Coriolous Dersicolor (Fr.) Quel 25 parts, the Radix Linderae 25 parts, Flos Bombacis Malabarici 20 parts, Rhizoma Alismatis 20 parts, Herba Orostachyos 15 parts, Radix Cyathulae 20 parts.
Preferably, described wasp wine, it is prepared by the raw materials in: 1000 parts of the rice wine of 55 °, fresh and alive wasp
150 parts, Coriolous Dersicolor (Fr.) Quel 20 parts, the Radix Linderae 20 parts, Flos Bombacis Malabarici 15 parts, Rhizoma Alismatis 15 parts, Herba Orostachyos 10 parts, Radix Cyathulae 15 parts.
A kind of method preparing wasp wine of the present invention, comprises the steps of
(1) rice wine, fresh and alive wasp are weighed respectively by parts by weight of raw materials;Fresh and alive wasp Reticular breathable plastic bottle is installed also
Insert in rice wine and soak, standby;
(2) raw material is weighed respectively by parts by weight of raw materials: Coriolous Dersicolor (Fr.) Quel, the Radix Linderae, Flos Bombacis Malabarici, Rhizoma Alismatis, Herba Orostachyos, Radix Cyathulae;Machinery powder
Broken standby;
(3) by step (1) and the product of step (2) gained, together it is positioned in a Porcelain Jar immersion and i.e. obtains into for 1-2 month
Product.
Further, in step (3), described immersion is to carry out at a temperature of 25~30 DEG C.
Raw material effect used by the present invention is as follows:
Wasp, for the polypide of Vespidae insecticide wasp VespaManificaSmith, have keep fit, benefit the intestines and stomach, pain relieving, reason
Gas, reduce phlegm, the effect such as anthelmintic looks improving and the skin nourishing.
Coriolous Dersicolor (Fr.) Quel, being dried for On Polyporaceae Corilus versicolor Quel. Coriolus versicolor (L.ex Fr.) Quel
Sporophore.There is invigorating spleen to remove dampness, effect of heat-clearing and toxic substances removing.
The Radix Linderae, for the dried root of canella Radix Linderae Lindera aggregata (Sims) Kosterm..There is circulation of qi promoting
Pain relieving, effect of warming kidney for dispelling cold.
Flos Bombacis Malabarici, for the dry flower of Bombacaceae plant kapok Gossampinus malabarica (DC.) Merr..Have
Clearing away heat-damp and promoting diuresis, effect of removing toxic substances.
Rhizoma Alismatis, for the dry tuber of Notes On Alism At Aceae Rhizoma Alismatis Alisma orientale (Sam.) Juzep..There is diuretic
Eliminating dampness by diuresis, expels the heat-evil, and changes effect of turbid blood fat reducing.
Herba Orostachyos, for the dry aerial parts of crassulaceae plants Herba Orostachyos Orostachys fimbriata (Turcz.) Berg..
There is cooling blood for hemostasis, effect of removing toxic substances.
Radix Cyathulae, for the dry root of amaranthaceous plant Radix Cyathulae Cyathula offinalis Kuan.There is eliminating blood stasis and inducing menstruation,
Easing joint movement, effect of inducing diuresis for treating stranguria syndrome.
Chinese medicine thinks pathogenic characteristic many genus deficiency in origin and excess in superficiality of gout, and with caused by liver and kidney deficiency, dysfunction of the spleen in transportation is this;Wind and cold is wet
Heat, expectorant are turbid, Yu Xue Bi resistance passages through which vital energy circulates is mark.
Treat appropriate to the occasion employing treating both the principal and secondary aspects of a disease, with Da Peiben primordial QI reinforcing, treatment must aim at the pathogenesis of disease.With invigorating spleen and kidney, reduce phlegm that to let out turbid be basic
Rule for the treatment of, is aided with the turbid descending removing toxic substances, activating blood circulation to dissipate blood stasis medicine, to promote turbid letting out of poison, releases the knot that becomes silted up.
In the present invention, Coriolous Dersicolor (Fr.) Quel invigorating spleen to remove dampness, heat-clearing and toxic substances removing;Radix Linderae promoting the circulation of QI to relieve pain, warming kidney for dispelling cold;Flos Bombacis Malabarici clearing away heat-damp and promoting diuresis,
Removing toxic substances;Rhizoma Alismatis promoting diuresis to eliminate damp pathogen, expels the heat-evil, and changes turbid blood fat reducing;Herba Orostachyos cooling blood for hemostasis, removing toxic substances;Radix Cyathulae eliminating blood stasis and inducing menstruation, easing joint movement, profit
Urinate treating stranguria;Wasp activating QI to eliminate phlegm, QI and blood regulating.
In sum, inventive formulation is scientific and reasonable, and all medicines coordinate, and plays invigorating spleen and kidney altogether, reduces phlegm that it is turbid to let out, and the turbid descending detoxifies,
The merit of activating blood circulation to dissipate blood stasis.Full side's treating both the principal and the secondary aspects of a disease at the same time, appropriate pathogenesis.Through clinic trial, treatment gout effect is notable.
[detailed description of the invention]
Embodiment 1
The wasp wine of the present embodiment, is prepared by the raw materials in: 500 parts of the rice wine of 50 °, fresh and alive wasp 100 parts,
Coriolous Dersicolor (Fr.) Quel 15 parts, the Radix Linderae 15 parts, Flos Bombacis Malabarici 10 parts, Rhizoma Alismatis 10 parts, Herba Orostachyos 5 parts, Radix Cyathulae 10 parts.
The preparation method of the present embodiment wasp wine is:
(1) rice wine, fresh and alive wasp are weighed respectively by parts by weight of raw materials;Fresh and alive wasp Reticular breathable plastic bottle is installed also
Insert in rice wine and soak, standby;
(2) raw material is weighed respectively by parts by weight of raw materials: Coriolous Dersicolor (Fr.) Quel, the Radix Linderae, Flos Bombacis Malabarici, Rhizoma Alismatis, Herba Orostachyos, Radix Cyathulae;Machinery powder
Broken standby;
(3) by step (1) and the product of step (2) gained, together it is positioned in a Porcelain Jar at a temperature of 25~30 DEG C
Soak and get product for 1 month.
Embodiment 2
The wasp wine of the present embodiment, is prepared by the raw materials in: 1500 parts of the rice wine of 60 °, fresh and alive wasp 200
Part, Coriolous Dersicolor (Fr.) Quel 25 parts, the Radix Linderae 25 parts, Flos Bombacis Malabarici 20 parts, Rhizoma Alismatis 20 parts, Herba Orostachyos 15 parts, Radix Cyathulae 20 parts.
The preparation method of the present embodiment wasp wine is:
(1) rice wine, fresh and alive wasp are weighed respectively by parts by weight of raw materials;Fresh and alive wasp Reticular breathable plastic bottle is installed also
Insert in rice wine and soak, standby;
(2) raw material is weighed respectively by parts by weight of raw materials: Coriolous Dersicolor (Fr.) Quel, the Radix Linderae, Flos Bombacis Malabarici, Rhizoma Alismatis, Herba Orostachyos, Radix Cyathulae;Machinery powder
Broken standby;
(3) by step (1) and the product of step (2) gained, together it is positioned in a Porcelain Jar at a temperature of 25~30 DEG C
Soak and get product for 2 months.
Embodiment 3
The wasp wine of the present embodiment, is prepared by the raw materials in: 1000 parts of the rice wine of 55 °, fresh and alive wasp 150
Part, Coriolous Dersicolor (Fr.) Quel 20 parts, the Radix Linderae 20 parts, Flos Bombacis Malabarici 15 parts, Rhizoma Alismatis 15 parts, Herba Orostachyos 10 parts, Radix Cyathulae 15 parts.
The preparation method of the present embodiment wasp wine is with embodiment 1.
Experimental example: the wasp wine of the present invention curative effect to gout
1, physical data:
300 example patients are carried out clinical observation treatment, age 32~65 years old, is gout.
Diagnostic criteria: acute attack or recurrent exerbation redness and swelling of joints, pain, blood uric acid increases.
2, medicine:
Embodiment 1~3.
3, Therapeutic Method:
300 example cases being randomly divided into 3 groups, often organizes 100 examples, each group of wasp wine using embodiment 1~3 respectively is controlled
Treat.
The using method of wasp wine is: illing skin is sterilized, and with percussopunctator tapping or clamps skin-test needle with mosquito forceps,
Expose syringe needle about 2mm, prick illing skin gently, be preferred to skin slightly oozing of blood point, wipe after blood point solidifies, use the present invention
Wasp wine coat, treat a moment, pat 5~10 minutes with sticking plaster or bamboo chip, repaste medicated wine, beating, be so repeated 3 times, often
Secondary dosage is 5ml, within 1 day, treats 2~3 times, and second time no longer pricks skin with pin mark later, a coating, pats.One month
It it is a course for the treatment of.
4, efficacy assessment standard
Recovery from illness: clinical symptom disappearance, blood uric acid is down to normally.
Effective: clinical symptom disappearance, blood uric acid does not drops.
Invalid: clinical symptoms and blood uric acid are without changing.
5, experimental result
Table 1 embodiment 1~3 curative effect to treatment gout
Group | Recovery from illness | Effective | Invalid | Total effective rate |
Embodiment 1 | 66 | 33 | 1 | 99% |
Embodiment 2 | 63 | 35 | 2 | 98% |
Embodiment 3 | 67 | 32 | 1 | 99% |
Can be seen that present invention application clinically has significant curative effect.
The most all patient is followed up a case by regular visits to after treating a course for the treatment of, continue half a year, do not find the sign of recurrence.
Described above is the detailed description for the preferable possible embodiments of the present invention, but embodiment is not limited to this
Bright patent claim, the equal change completed under the technical spirit suggested by all present invention or modification change, all should belong to
In the contained the scope of the claims of the present invention.
Claims (6)
1. the wasp wine treating gout, it is characterised in that be prepared by the raw materials in: the rice wine 500 of 50~60 °
~1500 parts, fresh and alive wasp 100~200 parts, Coriolous Dersicolor (Fr.) Quel 15~25 parts, the Radix Linderae 15~25 parts, Flos Bombacis Malabarici 10~20 parts, Rhizoma Alismatis 10~
20 parts, Herba Orostachyos 5~15 parts, Radix Cyathulae 10~20 parts.
2. wasp wine as claimed in claim 1, it is characterised in that be prepared by the raw materials in: the rice wine 500 of 50 °
Part, fresh and alive wasp 100 parts, Coriolous Dersicolor (Fr.) Quel 15 parts, the Radix Linderae 15 parts, Flos Bombacis Malabarici 10 parts, Rhizoma Alismatis 10 parts, Herba Orostachyos 5 parts, Radix Cyathulae 10 parts.
3. wasp wine as claimed in claim 1, it is characterised in that be prepared by the raw materials in: the rice wine 1500 of 60 °
Part, fresh and alive wasp 200 parts, Coriolous Dersicolor (Fr.) Quel 25 parts, the Radix Linderae 25 parts, Flos Bombacis Malabarici 20 parts, Rhizoma Alismatis 20 parts, Herba Orostachyos 15 parts, Radix Cyathulae 20 parts.
4. wasp wine as claimed in claim 1, it is characterised in that be prepared by the raw materials in: the rice wine 1000 of 55 °
Part, fresh and alive wasp 150 parts, Coriolous Dersicolor (Fr.) Quel 20 parts, the Radix Linderae 20 parts, Flos Bombacis Malabarici 15 parts, Rhizoma Alismatis 15 parts, Herba Orostachyos 10 parts, Radix Cyathulae 15 parts.
5. the method for the wasp wine that one kind is prepared described in any one of claim 1-4, it is characterised in that comprise the steps of
(1) rice wine, fresh and alive wasp are weighed respectively by parts by weight of raw materials;Fresh and alive wasp is installed with Reticular breathable plastic bottle and is placed into
Rice wine soaks, standby;
(2) raw material is weighed respectively by parts by weight of raw materials: Coriolous Dersicolor (Fr.) Quel, the Radix Linderae, Flos Bombacis Malabarici, Rhizoma Alismatis, Herba Orostachyos, Radix Cyathulae;Mechanical activation comminution is standby
With;
(3) by step (1) and the product of step (2) gained, together it is positioned in a Porcelain Jar immersion and gets product for 1-2 month.
6. method as claimed in claim 5, it is characterised in that in step (3), described immersion is at a temperature of 25~30 DEG C
Carry out.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610914510.9A CN106214880A (en) | 2016-10-20 | 2016-10-20 | A kind of wasp wine treating gout |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610914510.9A CN106214880A (en) | 2016-10-20 | 2016-10-20 | A kind of wasp wine treating gout |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106214880A true CN106214880A (en) | 2016-12-14 |
Family
ID=58077071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610914510.9A Pending CN106214880A (en) | 2016-10-20 | 2016-10-20 | A kind of wasp wine treating gout |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106214880A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1706453A (en) * | 2005-05-16 | 2005-12-14 | 广州固志医药科技开发有限公司 | Gout resisting Chinese medicine composition and its prepn process |
CN1709454A (en) * | 2005-07-04 | 2005-12-21 | 北京润德康医药科技有限公司 | Chinese medicine formulation for treating arthrolithiasis, and its preparing method |
-
2016
- 2016-10-20 CN CN201610914510.9A patent/CN106214880A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1706453A (en) * | 2005-05-16 | 2005-12-14 | 广州固志医药科技开发有限公司 | Gout resisting Chinese medicine composition and its prepn process |
CN1709454A (en) * | 2005-07-04 | 2005-12-21 | 北京润德康医药科技有限公司 | Chinese medicine formulation for treating arthrolithiasis, and its preparing method |
Non-Patent Citations (1)
Title |
---|
倪青等: "高尿酸血症和痛风中医认识与治疗", 《北京中医药》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100367998C (en) | Miao-Nationality medicated liquor for treating fractures and fractures from falling | |
CN102526275B (en) | Pharmaceutical for curing gout and preparation method thereof | |
CN107137529A (en) | A kind of Chinese medicinal ointment for treating wrist joint bruise and preparation method thereof | |
CN1772245A (en) | Snake medicinal wine for health care massage and its application | |
CN106924710A (en) | A kind of Chinese medicine preparation of inside and outside two-way treatment gout and preparation method thereof | |
CN102961633B (en) | A kind of preparation for being used to treat postpartum rheumatism | |
CN101983650A (en) | Medicament for treating dermatitis aestivale | |
CN106214880A (en) | A kind of wasp wine treating gout | |
CN101199601B (en) | Naze rheumatism medicated liquor | |
CN103751703A (en) | Chinese herbal medicinal liquor used for treating arthromyodynia and preparation method thereof | |
CN100522219C (en) | Medicine for preventing bedsore | |
CN104857089B (en) | A kind of decoction for treating rheumatism and rheumatoid arthritis and preparation method thereof | |
CN104474049B (en) | A kind of Traditional Chinese medicinal spray and preparation method thereof | |
CN106237086A (en) | A kind of wasp wine treating gout | |
CN105232799A (en) | Bathing liquid for treating acute gout | |
CN105616947A (en) | Heat and dampness removing traditional Chinese medicine for treating acute gouty arthritis | |
CN106361840A (en) | Traditional Chinese medicine composite used for treating rheumatism and preparing method thereof | |
CN105687956A (en) | Traditional Chinese medicine ointment for treating allergic dermatitis and preparation method | |
CN106552011A (en) | A kind of the kidney warming QI invigorating footbath with traditional Chinese medicines health care prescription | |
CN105267321A (en) | Medicine for treating gouty arthritis | |
CN103656086B (en) | The Chinese medicine preparation for the treatment of urarthritis | |
CN100584368C (en) | Medicine for treating rheumatoid and rheumatoid arthritis and its preparation method | |
CN117211107A (en) | Traditional Chinese medicine rice paper with physiotherapy effect and preparation method thereof | |
CN106389971A (en) | Wasp wine for treating gout | |
CN102166290B (en) | Medicine for treating cupmoth larvae sting |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161214 |
|
RJ01 | Rejection of invention patent application after publication |